Marker-free cell discrimination by holographic optical tweezers by Schaal, F. et al.
J O U R N A L  O F
T
O
R
H E  E U R O P E A N  
P T I C A L  S O C I E T Y
A PID  PU B LIC AT IO N S
Journal of the European Optical Society - Rapid Publications 4, 09028 (2009) www.jeos.org
Marker-free cell discrimination by holographic optical
tweezers
F. Schaal
schaal@ito.uni-stuttgart.de
University of Stuttgart, Institut fu¨r Technische Optik, Stuttgart, 70569, Germany.
M. Warber University of Stuttgart, Institut fu¨r Technische Optik, Stuttgart, 70569, Germany.
S. Zwick University of Stuttgart, Institut fu¨r Technische Optik, Stuttgart, 70569, Germany.
H. van der Kuip Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University
of Tuebingen, 70376, Germany.
T. Haist University of Stuttgart, Institut fu¨r Technische Optik, Stuttgart, 70569, Germany.
W. Osten University of Stuttgart, Institut fu¨r Technische Optik, Stuttgart, 70569, Germany.
We introduce a method for marker-free cell discrimination based on optical tweezers. Cancerous, non-cancerous, and drug-treated cells
could be distinguished by measuring the trapping forces using holographic optical tweezers. We present trapping force measurements
on different cell lines: normal pre-B lymphocyte cells (BaF3; “normal cells”), their Bcr-Abl transformed counterparts (BaF3-p185; “cancer
cells”) as a model for chronic myeloid leukaemia (CML) and Imatinib treated BaF3-p185 cells. The results are compared with reference
measurements obtained by a commercial flow cytometry system. [DOI: 10.2971/jeos.2009.09028]
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1 INTRODUCTION
Discrimination of different cells and cell states is important
for identification of diseases, treatment monitoring, and indi-
cation of drug response in clinical diagnosis and biomedical
research. Therefore, a lot of methods have been developed in
the past for differentiating cells. Due to their high speed and
the contactless operation, optical methods are especially use-
ful for this purpose.
Image-processing based techniques that classify different cells
have already attained impressive results, but for many appli-
cations methods which purely rely on simple dyeing or phase-
contrast techniques are not powerful enough. Figure 1 shows
a typical example that will be used later on in this article: the
cancerous and non-cancerous white blood cells look exactly
the same. Discrimination based solely on images is not pos-
sible. Therefore, often more sophisticated methods are neces-
sary.
FIG. 1 Microscopic bright-field images of BaF3 (“normal cells”), BaF3-p185 (“cancer
cells”) and Imatinib treated BaF3-p185 cells
Most often, the binding of specially marked molecules to
their corresponding targets is employed. Detection is then per-
formed manually or in an automated way based on imaging
or flow cytometry. Fluorescence-based methods (e.g. fluores-
cence activated cell sorting (FACS)) are especially widely used
in immunology [1, 2]. Applications for such techniques range
from the simple diagnosis of pregnancy to the detection of
cancerous cells.
Unfortunately, the application of marker-based methods also
has some drawbacks. Most importantly, a suitable marker
first has to be developed. Such a development (including
approval) is typically very expensive. Additionally, often la-
borious biochemical preparation has to be performed before
marking is possible. This potentially leads to influences on the
cells and the measurement results, e.g. by reducing the cell
viability. Due to these disadvantages, a lot of research is cur-
rently directed towards the development of marker-free de-
tection methods.
Today, optical marker-free detection in a clinical environment
is especially based on stray-light analysis [3]–[5] (e.g. using
Doppler anemometers or interference-based setups) but a lot
of other techniques can also deliver important information.
Examples are autofluorescence-based methods, spectroscopy
[6] (e.g. Raman-based), and quantitative phase contrast mi-
croscopy [7, 8]. The incorporation of the behaviour over time
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(e.g. time-gated fluorescence) might also give valuable infor-
mation [9].
A new class of optical methods for diagnosis employs the
action of force that light is able to exert onto relevant parti-
cles like cells or viruses. Specifically, it is possible to measure
the mechanical parameters of different cell states by system-
atically deforming the cells using optical cell stretchers [10]–
[12]. Another interesting class of methods measures the force-
coupling to secondary objects (typically coated or uncoated
microbeads) [13]. These methods are very powerful for clini-
cal research but not very much suited for a cost-effective au-
tomated system.
Ladavac et al. proposed a system where cells are sorted based
on their movement in a light field. [14] Such “optical sorting”
methods have shown themselves to be sensitive of the refrac-
tive index and the size of the cell [15]. Additionally, Dhar-
madhikari et al. and Mohanty et al. have shown that optical-
induced rotation of erythrocytes can be used for the early de-
tection of malaria [16, 17]. The classification of HeLa cells [18],
viruses [3], and yeast cells [19] has also been demonstrated.
Martin et al. [12] have shown the discrimination of different
breast cancer cells by measuring the optical deformabiliy.
In the following we describe a method that uses the light-
induced force for discriminating cells that are indistinguish-
able by conventional image analysis (Figure 1). Optical tweez-
ers are able to trap and move micro-objects. The trapping force
depends on the shape, the structure, and the relative index of
refraction of the object and the surrounding medium. Differ-
ent cells or cells in a different state lead to different trapping
forces, depending on the cell type, cell structure, metabolic ac-
tivity, and drug treatment.
We employ a holographic optical tweezers (HOT) system for
performing escape-force measurements on pre-B lymphocyte
cells. Section 2 describes the optical setup and in Section 3 we
show the results for these cells as well as reference measure-
ments obtained with a commercial flow cytometry system. Fi-
nally, we give a short summary and an outlook in Section 4.
2 EXPERIMENTAL SETUP
The method uses a system based on holographic optical
tweezers [20]. The setup (Figure 2) consists of a 20 W diode
pumped Nd:YAG laser (λ = 1064 nm) running at 4,9 W,
which illuminates a reflective phase-only spatial light mod-
ulator (Holoeye HEO 1080P) with 2 million pixels, 8 µm pixel
pitch and 2pi phase modulation at λ = 1064 nm. A phase holo-
gram is computed and written into the light modulator. Op-
tical traps are then generated by reconstructing the hologram
in the object plane of the microscope. By the digital hologram
we are able to generate hundreds of optical traps and move
them independently in all three dimensions with a position-
ing accuracy better than 10 nm.
To allow real time movement of the traps, the hologram com-
putation is done on a graphics board (Nvidia 6800 GT) [21].
The system is operating at a wavelength of λ = 1064 nm to
minimize the damage by light absorption in biological objects
[22]. The light modulator and the microscope (Zeiss Axiovert
200M) are coupled by a telescope and a dichroic beam split-
ter. A detailed analysis of the setup is described by Haist et al.
[23]. The high numerical aperture water immersion lens (Zeiss
C-Apochromat 40× NA 1.2) is used to obtain good trapping
efficiency and high resolution imaging. Images of the object
plane were recorded using a Zeiss AxioCam MRm CCD cam-
era.
FIG. 2 Setup of the holographic optical tweezers
Several methods for measuring the trapping force have been
proposed in the past. Examples are techniques based on Brow-
nian motion [24], oscillation [25], deflection or escape force
[26]. To keep the measurement time short we did not con-
sider methods based on thermal fluctuations. Therefore we
have chosen a trapping force measurement method, based on
Stokes friction (escape force method). The cells are trapped at
the holographically generated foci and accelerated until they
leave the trap due to the viscous drag. The geometry and max-
imum speed of the cells are measured by image processing.
The trapping forces are calculated using Stokes law. Measure-
ments were done on single cells with one optical trap. The
cells were trapped manually and lifted to a height of 50 µm
above the cover glass surface. To avoid interferences with
other cells, we used a cell concentration of 100.000 cells/ml
and discarded measurements with more than one cell inside
the microscope field.
We developed an image processing algorithm (Figure 3) to
track the cell movement and measure the cell diameter. To de-
tect the cells the edges were processed by a Canny algorithm
[27]. The output of the Canny algorithm is a binary image.
Possible small gaps on the edges are closed by dilatation. Af-
ter closing, the original cell diameter is restored by erosion.
Small areas are deleted in order to remove all filled areas be-
side the cell, e.g. other particles and artefacts. After that, the
area of the cell is filled. The cell position is computed as the
centroid of the filled area and the cell diameter is computed
by a circle fit of the cell profile. The cell diameter of moving
cells measured with this method has an average standard de-
viation of 0,2 µm.
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FIG. 3 Image processing: (a) camera image, (b) image after Canny algorithm, (c) image
after dilatation, (d) filling of closed areas and erosion, (e) removal of small areas, (f)
cell position during a measurement (100 images).
The cell speed is determined by differentiation of the time
dependent cell position (Figure 4). Internal flows in the sur-
rounding medium dragging the cells, might lead to wrong
measurements results. This is corrected by measuring the
speed of the cell after falling out of the trap and subtracting
this base speed from the maximum speed. Trapping force cal-
culation based on Stokes law for spherical particles is valid
due to the laminar flow around the cells (d ≈ 12 µm) and the
spherical shape of the measured cells. The trapping force is
then given by
F = 6pi r η vmax,
where the cell radius is denoted by r. The maximum cell speed
is vmax and the dynamic viscosity of the used medium RPMI
1640 (see Section 3) η equals 8.4× 10−4 Ns/m2.
FIG. 4 Cell speed during a trapping force measurement of a single cell. The cell is
trapped in a static optical trap between image 0 and 40. The cell is only moving due to
the Brownian motion. The optical trap is moving with increasing speed from image 40.
The cell leaves the optical trap, due to the increasing flow resistance at a maximum
speed of -12.4 µm/s at image 81. The cell quickly slows down and is dragged by the
surrounding flow in the medium with an average speed of -1,1 µm/s, between image
84 and 100.
3 EXPERIMENTAL RESULTS
Measurements were taken on different cell lines: normal pre-
B lymphocyte cells (BaF3; “normal cells”), their Bcr-Abl trans-
formed counterparts (BaF3-p185; “cancer cells”) as a model
for chronic myeloid leukemia (CML) and imatinib treated
BaF3-p185 cells. Imatinib is a molecularly targeted drug for
CML cancer treatment [28].
The parental murine pre-B lymphocyte cell line BaF3 and the
p185 Bcr-Abl expressing derivative thereof, BaF3p185, were a
kind gift from Prof. J. Duyster (Munich, Germany). BaF3p185
was transformed with pSLXBcr-Abl. Parental BaF3 cells were
grown in RPMI 1640 (Biochrom, Berlin, Germany) comple-
mented with 10% fetal calf serum, glutamine, and 1 ng/mL re-
combinant murine IL-3 (PBH, Hannover, Germany) whereas
the factor independent BaF3-p185 cells were grown without
additional growth factor supplementation.
Imatinib mesylate (STI571; Glivec) is a specific inhibitor of the
c-Abl and Bcr-Abl-kinase and was purchased from Toronto
Research Chemicals inc. (North York, Canada). A stock solu-
tion (10 mg/ml) was prepared by dissolving the compound
in DMSO/H2O (1:1) and kept at -20◦C. Cells were incubated
with or without 3 µM/ml Imatinib for 120 min. and then har-
vested.
Trapping force measurements for a series of 200 cells were
taken of BaF3, BaF3-p185 and 2 hours Imatinib treated BaF3-
p185 cells. Each measurement series was repeated once. The
trapping force distribution of BaF3 and BaF3-p185 cells is
shown in Figure 5. Figure 6 contains the trapping force dis-
tribution of BaF3-p185 and Imatinib treated cells. A Gaussian
curve is fitted on histograms of the trapping force distribu-
tions. The histograms of cancerous and normal cells (Figure 5)
can be clearly distinguished by their standard deviation. The
standard deviation of the cancerous cells (3.5× 10−13 N) is sig-
nificantly wider than the standard deviation of normal cells
(1.8 × 10−13 N). Cancerous and drug-treated cancerous cells
(Figure 6) can be separated by their peak values. The trapping
force distribution peak value of cancerous cells (1.2× 10−12 N)
is smaller than the peak value of Imatinib treated cancer cells
(1.4× 10−12 N).
We also performed flow cytometry measurements of BaF3-
p185 and 3 µM/ml Imatinib treated BaF3-p185 cells after dif-
ferent incubation times (Figure 7). The fluorescent markers for
early cell death processes TMRM and Annexin V were used
to distinguish untreated and Imatinib treated BaF3-p185 cells.
In contrast to the trapping force based method untreated and
Imatinib treated cells could not be distinguished after 2 hours
incubation.
Moehring et al. [29] measured a rapid increase of poly(ADP-
ribosyl)ation in BaF3-p185 cells after 2 hours Imatinib expo-
sure by Western blot analysis. This indicates differences in the
molecular structure between Imatinib treated and untreated
BaF3-p185 cells after 2 hours Imatinib exposure.
We measured no significant discrepancy between the cell di-
ameter distributions (Figure 8) of the different cell types. Also
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FIG. 5 Trapping forces of BaF3 cells (“normal cells”) and BaF3-p185 cells (“cancer cells”)
FIG. 6 Trapping forces of BaF3-p185 cells (“cancer cells”) and Imatinib treated BaF3-
p185 cells after 2 hours drug exposure
no significant change in the cell cross sectional area during a
trapping force measurement was observed.
The cause for the observed effect is not identified yet. Some-
how the interaction of light with the cell is changed by the
different cell state. This might be due to a simple change of
refractive index or shape, but might be also due to much more
complicated issues. Absorption and light deflection due to the
internal cell structures is in a complicated way also important
for the transfer of momentum and therefore force. This means
that one would have to know this detailed fine structure and
its changes and then one would have to model the light deflec-
tion using some sort of rigorous electrodynamic modelling.
We think that this is not possible at the state of art. Still, medi-
cal application is possible using the proposed method/results.
4 SUMMARY AND OUTLOOK
We have shown that holographic optical tweezers can be
used to discriminate between normal, cancerous and drug-
FIG. 7 FACS measurements of Imatinib treated and untreated BaF3-p185 cells (“cancer
cells”) marked with the fluorescent markers for early cell death processes TMRM and
Annexin V
FIG. 8 Cell diameter distribution
treated cancerous leucocytes without using additional mark-
ers. Moreover, the optical force that a focused light beam
exerts onto the cell seems to be more sensitive to changes
of the cell than the standard FACS-based measurement with
fluorescence-based markers. For the force measurement we
use an escape force approach using image processing-based
evaluation. In principle, the method can be completely auto-
mated so that diagnosis without additional markers should be
possible in a cost effective way for isolated cells.
Compared to most other methods there is no need for diffi-
cult or time-consuming preparation of the cells and the cells
are not damaged by the measurement. Sorting of the dis-
criminated cells by active movement using the holographic
technique is also in principle possible. Since only one inte-
gral parameter, namely the force acting onto the particle, is
measured it might be advantageous to combine the method
with other techniques that deliver additional information.
We think that the combination with phase contrast imaging
and morphology-based features is especially interesting for a
broad range of applications.
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